Bausch & Lomb Corp Selling, General and Administrative Expense
Bausch & Lomb Corp (BLCO) reported Selling, General and Administrative Expense of $588.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- Bausch & Lomb Corp selling, general and administrative expense for the quarter ending 2026-06-30 was $588.00M, a 1.55% increase year-over-year.
- Bausch & Lomb Corp selling, general and administrative expense for the quarter ending 2026-03-31 was $544.00M, a 3.37% decline year-over-year.
- Bausch & Lomb Corp selling, general and administrative expense for the quarter ending 2025-12-31 was $564.00M, a 6.02% increase year-over-year.
- Bausch & Lomb Corp selling, general and administrative expense for the quarter ending 2025-09-30 was $528.00M, a 3.33% increase year-over-year.
- Bausch & Lomb Corp selling, general and administrative expense for fiscal 2025 was $2.23B, a 7.30% increase from fiscal 2024.
- Bausch & Lomb Corp selling, general and administrative expense for fiscal 2024 was $2.08B, a 19.93% increase from fiscal 2023.
- Bausch & Lomb Corp selling, general and administrative expense for fiscal 2023 was $1.74B, a 17.46% increase from fiscal 2022.
- Bausch & Lomb Corp selling, general and administrative expense for fiscal 2022 was $1.48B, a 6.41% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $588.00M 10-Q · filed 2026-07-29 | $1.13B 10-Q · filed 2026-07-29 | $1.70B derived: sum of 3 quarters · filed 2026-07-29 | $2.22B derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $544.00M 10-Q · filed 2026-04-29 | $1.11B derived: sum of 2 quarters · filed 2026-04-29 | $1.64B derived: sum of 3 quarters · filed 2026-04-29 | $2.21B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $564.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.09B derived: sum of 2 quarters · filed 2026-02-18 | $1.67B derived: sum of 3 quarters · filed 2026-07-29 | $2.23B 10-K · filed 2026-02-18 |
| 2025-09-30 | $528.00M 10-Q · filed 2025-10-29 | $1.11B derived: sum of 2 quarters · filed 2026-07-29 | $1.67B 10-Q · filed 2025-10-29 | $2.20B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $579.00M 10-Q · filed 2026-07-29 | $1.14B 10-Q · filed 2026-07-29 | $1.67B derived: sum of 3 quarters · filed 2026-07-29 | $2.19B derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $563.00M 10-Q · filed 2026-04-29 | $1.09B derived: sum of 2 quarters · filed 2026-04-29 | $1.61B derived: sum of 3 quarters · filed 2026-04-29 | $2.14B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $532.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.04B derived: sum of 2 quarters · filed 2026-02-18 | $1.58B derived: sum of 3 quarters · filed 2026-02-18 | $2.08B 10-K · filed 2026-02-18 |
| 2024-09-30 | $511.00M 10-Q · filed 2025-10-29 | $1.05B derived: sum of 2 quarters · filed 2025-10-29 | $1.55B 10-Q · filed 2025-10-29 | $2.03B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $535.00M 10-Q · filed 2025-07-30 | $1.04B 10-Q · filed 2025-07-30 | $1.52B derived: sum of 3 quarters · filed 2026-02-18 | $1.94B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $504.00M 10-Q · filed 2025-04-30 | $987.00M derived: sum of 2 quarters · filed 2026-02-18 | $1.41B derived: sum of 3 quarters · filed 2026-02-18 | $1.82B derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $483.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $901.00M derived: sum of 2 quarters · filed 2026-02-18 | $1.32B derived: sum of 3 quarters · filed 2026-02-18 | $1.74B 10-K · filed 2026-02-18 |
| 2023-09-30 | $418.00M 10-Q · filed 2024-10-30 | $835.00M derived: sum of 2 quarters · filed 2024-10-30 | $1.25B 10-Q · filed 2024-10-30 | $1.64B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $417.00M 10-Q · filed 2024-08-01 | $835.00M 10-Q · filed 2024-08-01 | $1.22B derived: sum of 3 quarters · filed 2025-02-19 | $1.60B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $418.00M 10-Q · filed 2024-05-01 | $804.00M derived: sum of 2 quarters · filed 2025-02-19 | $1.19B derived: sum of 3 quarters · filed 2025-02-19 | $1.55B derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $386.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $767.00M derived: sum of 2 quarters · filed 2025-02-19 | $1.14B derived: sum of 3 quarters · filed 2025-02-19 | $1.48B 10-K · filed 2025-02-19 |
| 2022-09-30 | $381.00M 10-Q · filed 2023-11-01 | $749.00M derived: sum of 2 quarters · filed 2023-11-01 | $1.09B 10-Q · filed 2023-11-01 | $1.46B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $368.00M 10-Q · filed 2023-08-02 | $711.00M 10-Q · filed 2023-08-02 | $1.08B derived: sum of 3 quarters · filed 2024-02-21 | $1.42B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $343.00M 10-Q · filed 2023-05-03 | $708.00M derived: sum of 2 quarters · filed 2024-02-21 | $1.06B derived: sum of 3 quarters · filed 2024-02-21 | $1.41B derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $365.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $713.00M derived: sum of 2 quarters · filed 2024-02-21 | $1.07B derived: sum of 3 quarters · filed 2024-02-21 | $1.39B 10-K · filed 2024-02-21 |
| 2021-09-30 | $348.00M 10-Q · filed 2022-11-02 | $706.00M derived: sum of 2 quarters · filed 2022-11-02 | $1.02B 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $358.00M 10-Q · filed 2022-08-04 | $676.00M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $318.00M 10-Q · filed 2022-06-08 | |||
| 2020-12-31 | $1.25B 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |